Atea Pharmaceuticals (AVIR) Net Margin (2021)
Atea Pharmaceuticals' Net Margin history spans 1 years, with the latest figure at 60.95% for Q4 2021.
- Quarterly Net Margin changed N/A to 60.95% in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 34.49% through Dec 2021, changed N/A year-over-year, with the annual reading at 34.49% for FY2021, 5700.0% up from the prior year.
- Net Margin came in at 60.95% for Q4 2021, up from 85.93% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 60.95% in Q4 2021 to a low of 85.93% in Q3 2021.